Poverty and cognitive function EB Dean, F Schilbach, H Schofield The economics of poverty traps, 57-118, 2017 | 113 | 2017 |
Government fragmentation and public goods provision G Grossman, JH Pierskalla, E Boswell Dean The Journal of Politics 79 (3), 823-840, 2017 | 90 | 2017 |
Food insecurity, health care utilization, and health care expenditures EB Dean, MT French, K Mortensen Health services research 55, 883-893, 2020 | 55 | 2020 |
Who benefits from pharmaceutical price controls?: Evidence from india EB Dean Center for Global Development, 2019 | 19 | 2019 |
Physician, practice, and patient characteristics associated with biosimilar use in Medicare recipients EB Dean, P Johnson, AM Bond JAMA network open 4 (1), e2034776-e2034776, 2021 | 11 | 2021 |
The future of global health procurement: Issues around pricing transparency M Berdud, K Chalkidou, EB Dean, J Ferraro, L Garrison, C Nemzoff, ... Center for Global Development 50 (7), 27-31, 2019 | 10 | 2019 |
The economics of poverty traps EB Dean, F Schilbach, H Schofield National Bureau of Economic Research, Washington, DC, 2017 | 7 | 2017 |
Who benefits from pharmaceutical price ceilings EB Dean Evidence from India, 2017 | 5 | 2017 |
Using administrative data to examine telemedicine usage among Medicaid beneficiaries during the Coronavirus Disease 2019 pandemic M Hossain, EB Dean, D Kaliski Medical care 60 (7), 488, 2022 | 3 | 2022 |
Trends in Health Care Utilization and Expenditures in the United States across Five Decades: 1977–2017 K Mortensen, EB Dean, MT French, N Wang, J Chen Medical care 59 (8), 704, 2021 | 3 | 2021 |
Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market EB Dean, AM Bond JAMA health forum 2 (9), e212634-e212634, 2021 | 2 | 2021 |
Dengvaxia Controversy and Children's Vaccination in the Philippines J Yang, E Dean 2023 World Congress on Health Economics, 2023 | | 2023 |
The Role Of Financial Incentives In Biosimilar Uptake In Medicare: Evidence From The 340B Program: Study examines the role of financial incentives in the uptake of biosimilar … AM Bond, EB Dean, SM Desai Health Affairs 42 (5), 632-641, 2023 | | 2023 |
The cost of care during times of COVID: Case study of TDABC and minimum utilization cost analysis in a medicare advantage population A Jacir, D Mendoza, E Dean, H Gitlow Journal of Health Care Finance, 2021 | | 2021 |
The Role of Financial Incentives in Biosimilar Uptake in Medicare: Evidence from the 340B Program A Mulcahy, E Dean, S Desai, A Bond 10th Annual Conference of the American Society of Health Economists, 2021 | | 2021 |
Physician Management Companies and Health Care Delivery: Evidence from Anesthesiology E Dean, A La Forgia, A Bond, T Braun, K Kjaer, LP Casalino 10th Annual Conference of the American Society of Health Economists, 2021 | | 2021 |
Hospital Acquisitions and Management Practices: Implications for Patient Health B Heebsh, A La Forgia, E Dean 9th Annual Conference of the American Society of Health Economists, 2020 | | 2020 |
Guilty until Proven Innocent: Industry Response to Scandal E Dean, S Schwab 9th Annual Conference of the American Society of Health Economists, 2020 | | 2020 |
Management Practices in Health Care A La Forgia, E Dean 9th Annual Conference of the American Society of Health Economists, 2020 | | 2020 |
Hospital Strategy and the Urban-Rural Divide: Implications for Labor and Delivery EB Dean 2019 Annual Research Meeting, 2019 | | 2019 |